ҽѧÂÛÎÄ·¢±í·ÖÎö¹¬ÄÚ½ÚÓýÆ÷µÄʹÓÃ(3)
3.3 ÍÑÂä
IUDÍÑÂäµÄ·¢Éú¶àÓëIUDÑ¡Ôñ²»µ±Óйأ¬ÈçÐͺŹýС¡¢IUDÖ§³ÅÁ¦ºÍ×Ó¹¬ÊÕËõÁ¦µÄ¹ØÏµ²»Æ½ºâµÈ¡£IUDÍÑÂä¶àÔÚÖû·ºóµÚ1Ä꣬·Å»·ºóǰ3¸öÔ³£¼û¡£
ÖܽàµÈ[21] ¶ÔÎÒ¹úÅ©´åµØÇø18922Ãû·ÅÖÃIUDµÄ¸¾Å®½øÐкá¶ÏÃæµ÷²éºÍÀúʷǰհÐÔËæ·Ã£¬½á¹ûÏÔʾ£ºIUDʹÓÃʧ°ÜÂʾÓÓÚǰÈýλµÄÊÇÍêÈ«ÍÑÂä¡¢ÏÂÒÆÈ¡Æ÷ºÍ´øÆ÷ÈÑÉï,ÆäÖÐÍêÈ«ÍÑÂäÀÛ¼ÆÊ§°ÜÂÊ(ÿ°ÙÃû¸¾Å®)·Ö±ðΪ:ʹÓÃ1¸öÔÂΪ0.33%,3¸öÔÂΪ1.13%,6¸öÔÂΪ2.21%,12¸öÔÂΪ4.30%¡£ MeirikµÈ[22]¹Û²ì¼ªÄÝ»·ÓëTCu380AµÄÁÙ´²¸±·´Ó¦£¬¿ÎÌâÉæ¼°8¸ö¹ú¼Ò£¬21¸öÖÐÐÄ£¬Ëæ¼´Ñ¡Ôñ1989¡«1993Äê¼ä¾ÍÕïµÄ»¼Õߣ¬¼ªÄÝ»·Ê¹ÓÃÕß2027ÈË(ÆäÖÐ43Àý·ÅÖÃʧ°Ü)£¬TCu380AʹÓÃÕß2036ÈË£¬¹Û²ìʱ¼äÀúʱ8Äê¡£½á¹û·¢ÏÖ£ºµÚÒ»Ä꼪ÄÝ»·µÄÍѳöÂÊΪ5.3/100£¬¶øTCu380AΪ2.5/100;Æäºó8ÄêÍѳöÂÊûÓвî±ð¡£Ìáʾ¼ªÄÝ»·µÄʹÓÃÔÚÔ¤·ÀÍÑÂä·½ÃæÓÅÓÚÆäËû½ÚÓýÆ÷¡£½üÄêÀ´£¬IUDµÄ²»¶ÏÑÐÖÆ¸Ä½ø£¬ÒÑʹÍÑÂäÂÊÃ÷ÏÔϽµ¡£ÔÚ·ÅÖÃǰ×Ðϸ²éÃ÷×Ó¹¬µÄλÖᢴóС£¬Ñ¡ÔñºÏÊʵÄIUDÐͺţ¬²ÅÄÜÓÐЧԤ·ÀIUDµÄÍÑÂä¡£
3.4 ´øÆ÷ÈÑÉï
IUDδ·ÅÖõ½¹¬µ×²¿»òÐÍºÅÆ«Ð¡£¬»òÏÂÒÆ¾ùÒ×µ¼Ö´øÆ÷ÈÑÉï¡£ÖܽàµÈ[21]µ÷²éÏÔʾ£º´øÆ÷ÈÑÉïÂÊ£¬Ê¹ÓÃIUD 1¸öÔÂΪ0.03%,3¸öÔÂΪ0.14%,6¸öÔÂΪ0.41%,12¸öÔÂΪ1.14%¡£ BednarekµÈ[23]Ôò·¢ÏÖʹÓÃLNG-IUS 1ÄêµÄÈÑÉïÂÊΪ0.1%¡£¹úÄÚÍâ´óÁ¿Ñо¿±íÃ÷[8]£¬ÔÚ»·µÄλÖÃÕý³£ÕßÖУ¬1/20ÈÑÉïϵÒìλÈÑÉIUD²¢²»Ôö¼ÓÒìλÈÑÉïµÄ·¢ÉúÂÊ£¬µ«Ëæ×Å´øÆ÷ʱ¼äµÄÑÓ³¤£¬ÓÈÆä³¬¹ý4ÄêÕߣ¬·¢ÉúÒìλÈÑÉï»ú»á½«»áÔö´ó£¬¹À¼ÆÓëIUD²úÉúµÄÒìÎï·´Ó¦£¬ËæÊ±¼äÑÓ³¤£¬Ó°ÏìÒ²Ç÷ÓÚÎȶ¨Óйء£´øÆ÷ÈÑÉï¿ÉÖÂÌ¥¶ùËðÉ˺ͻûÐΣ¬¹ÊÒ»µ©·¢Éú´øÆ÷ÈÑÉÔÔòÉÏÓ¦ÖÕÖ¹ÈÑÉͬʱȡ»·¡£´øÆ÷ÈÑÉïµÄ·¢Éú£¬Ìáʾ·Å»·ÊõºóµÄ¶¨ÆÚËæ·ÃÒâÒåÖØ´ó£¬Ó¦¸ÃÒýÆð¸ß¶È×¢Òâ¡£
IUDÓÃÓÚÈËÀàÒÑÓÐ100ÄêµÄÀúÊ·£¬ÈËÃDz»¶Ï½øÐÐÑо¿¸Ä½ø£¬ÒÔÌá¸ß±ÜÔÐЧ¹û£¬¼õÉÙ²»Á¼·´Ó¦£¬Í¬Ê±Æä×÷ÓÃÒ²´Óµ¥´¿ÓÃÓÚ±ÜÔз¢Õ¹µ½ÓÃÓÚ¶àÖÖ¸¾¿Æ¼²²¡µÄÖÎÁÆ£¬Æä²¢·¢Ö¢µÄÔ¤·ÀÒ²±»Ìá¸ßµ½Ò»¸öеÄÖØÊӸ߶ȣ¬ÓдýÓÚ×î´óÏ޶ȱÜÃâÆä·¢Éú¡£
IUDÌṩÁËÓë¾øÓýÊÖÊõÓÐÏàͬЧ¹ûµÄ±ÜÔз½·¨£¬¶øÇұȺóÕ߸üÓа²È«ÐÔ¡£ÓÐЧʹÓÃ10ÄêIUDµÄÈÑÉïÂÊÓëÊäÂѹܽáÔúÏàͬ¡£ÎÞÂÛÊÇÔÚ·¢´ï¹ú¼Ò»¹ÊÇ·¢Õ¹Öйú¼Ò£¬µÍ³É±¾µÄIUD »òLNG-IUSÄܹ»ÌṩÓÐЧµÄ±ÜÔз½·¨£¬¼õÉÙÁ˶ÔÊäÂѹܽáÔúºÍ×Ó¹¬ÇгýµÄÒÀÀµÐÔ¡£Òò´Ë£¬IUDÓпÉÄܳÉΪŮÐÔ¾øÓýÊÖÊõµÄÌæ´ú£¬ÓÈÆäÊÇÄÇЩÔÚ¾øÓýºó¸Ðµ½ºó»ÚµÄÄêÇáÅ®ÐÔ[8]¡£
¡¾²Î¿¼ÎÄÏס¿
1 Boukes FS, Kertzman MG, Smeenk RC, et al. Summary of the practice guideline“The intrauterine device”from the Dutch College of General Practitioners. Ned Tijdschr Geneeskd£¬2009£¬153:A578.
2 Zapata LB, Whiteman MK, Tepper NK, et al. Intrauterine device use among women with uterine fibroids: a systematic review.Contraception£¬ 2010£¬82(1):41-55.
3 Zapata LB, Whiteman MK, Marchbanks PA, et al. Intrauterine device use among women with ovarian cancer: a systematic review. Contraception£¬2010£¬82(1):38-40.
4 Smeets AJ, Nijenhuis RJ, Boekkooi PF, et al. Is an intrauterine device a contraindication for uterine artery embolization? A study of 20 patients. J Vasc Interv Radiol£¬2010£¬21(2):272-274.
5 Turok DK, Gurtcheff SE, Gibson K, et al. Operative management of intrauterine device complications: a case series report. Contraception£¬2010£¬82(4):354-357.
6 ÕÅϧÒõ.ʵÓø¾²ú¿ÆÑ§.±±¾©£ºÈËÃñÎÀÉú³ö°æÉ磬2004£¬986.
7 ÎâÉд¿£¬ÀîÀö£¬×ÞÑ࣬µÈ.Ô¾ÆÚ¼ä·ÅÖÃ7ÖÖ¹¬ÄÚ½ÚÓýÆ÷µÄÁÙ´²Ð§¹û±È½Ï.Öйú¼Æ»®ÉúÓýѧÔÓÖ¾£¬2008£¬16(9)£º552-556.
8 The ESHRE Capri Workshop Group. Intrauterine devices and intrauterine systems. Human Reproduction Update£¬2008£¬14(3):197-208.
9 ÀÖ½Ü.¸¾²ú¿ÆÑ§£¬µÚ7°æ.±±¾©£ºÈËÃñÎÀÉú³ö°æÉ磬2008£¬366.
10 Istanbulluoglu MO, Ozcimen EE, Ozturk B, et al. Bladder perforation related to intrauterine device. J Chin Med Assoc£¬2008£¬71(4):207-209.
11 Migraci Tosun MD, Handan Celik MD, Erhan Yavuz MD, et al. Intravesical migration of an intrauterine device detected in a pregnant woman . Can Urol Assoc J£¬2010£¬4(5):141-143.
12 Yensel U, Bezircioglu I, Yavuzcan A, et al. Migration of an intrauterine device into the bladder: a rare case. Arch Gynecol Obstet£¬2009£¬279(5):739-742.
13 G?kce MI, Süer E, Tangal S, et al. Squamous cell carcinoma of the bladder associated with chronic irritation related to a migrated intrauterine device. Scand J Urol Nephrol£¬2010£¬44(3) :183-185.
14 Vilallonga R, Rodriguez N, Vilchez M, et al. Translocation of an intrauterine contraceptive device: incidental finding in the rectosigmoid colon. Obstet Gynecol Int£¬2010,40(41)60 .
×ªÔØÇë×¢Ã÷À´×Ô£ºhttp://www.uuqikan.com/linchuangyixuelw/14909.html
- ˶²©±ÏÒµ·¢ÂÛÎÄ£¡ºÜÄѰÚÍÑÎÒÃüÓÉÎÒ²»
- ÈçºÎÔÚÆû³µµçÆ÷ÔÓÖ¾ÉÏ·¢±íÎÄÕÂ
- Æû³µÀàÆÚ¿¯ÓÐÄÄЩ
- ÂÛÎÄÈÝÒ×·¢±íµÄ4¸öС¼¼ÇÉ
- ºÃ·¢µÄÁÖÒµºËÐÄÆÚ¿¯
- ¼òÊöÔì¼Û¹¤³Ìʦִҵ¿¼ÊÔÌõ¼þ¼°Ö°³ÆÂÛ
- dz̸½¨Öþ¹ÜÀí¹¤³Ìʦְ³ÆÂÛÎÄ·¢±í»ã×Ü
- ÆÀÖ°³ÆÂÛÎıØÐëÊðÃûµÚÒ»×÷ÕßÂð
- ÒòÖ°³ÆÆÀ¶¨ÐèÒªÔÚºËÐÄÆÚ¿¯·¢±íÂÛÎĵÄ
- ¿ÚǻҽѧʲôѡÌâºÃ·¢±í
- µµ°¸×¨ÒµÁìÓòºËÐÄÆÚ¿¯
- MBAÊг¡ÓªÏú·½Ïò±ÏÒµÂÛÎÄÑ¡Ìâ²Î¿¼


